Researchers will test four experimental vaccines in a region in South Africa where one in five adults is infected with HIV.
Conor MyhrvoldFollow @twitterapi
I’m a former editorial intern at MIT Technology Review. Topics I am currently covering include the future of peer-review publishing, science startups, and what technology can tell us about nature, particularly elephants. I graduated from Princeton with an A.B. in Geosciences have completed the master’s program in Science Writing at MIT. I am also a metal aficionado.
Conor Myhrvold's Stories
The Harvard chemist talks about the problem of solving problems.
The way the disease tricks the body's defenses could help researchers develop better treatments.
A study suggests that a gene-suppressant could someday be delivered via a cream.
The success of "crowd-funding" inspired one researcher to create a Kickstarter-like service for scientists.
The virus is tamed in macaques.
Sanofi Pasteur's drug enters Phase III trials, bringing the first vaccine a step closer.
The new antismoking technique uses nanoparticles to trigger an immune response.